yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34420383-EB3D9C1F-BCC1-4503-8759-E8313DF51413
Q34420383-EB3D9C1F-BCC1-4503-8759-E8313DF51413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34420383-EB3D9C1F-BCC1-4503-8759-E8313DF51413
Emerging drugs for chronic kidney disease.
P2860
Q34420383-EB3D9C1F-BCC1-4503-8759-E8313DF51413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34420383-EB3D9C1F-BCC1-4503-8759-E8313DF51413
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3fd1a6139105f3ffe87761aa20921217e4287a93
P2860
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).